Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Specific keynote: hereditary ovarian cancer: what we know.

Literature DB >> 12586076

Specific keynote: hereditary ovarian cancer: what we know.

Jeff Boyd¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 12586076 DOI： 10.1006/gyno.2002.6674

Source DB: PubMed Journal: Gynecol Oncol ISSN： 0090-8258 Impact factor: 5.482

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.

Authors: Daichi Maeda; Satoshi Ota; Yutaka Takazawa; Kenichi Ohashi; Masaya Mori; Tetsuo Imamura; Shunsuke Nakagawa; Tetsu Yano; Yuji Taketani; Masashi Fukayama
Journal: Virchows Arch Date: 2010-09-25 Impact factor: 4.064

2. Recent progress in the diagnosis and treatment of ovarian cancer.

Authors: Danijela Jelovac; Deborah K Armstrong
Journal: CA Cancer J Clin Date: 2011-04-26 Impact factor: 508.702

3. Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

Authors: Robin A Lacour; Shannon N Westin; Larissa A Meyer; Shana N Wingo; John O Schorge; Rebecca Brooks; David Mutch; Ashley Molina; Rebecca Sutphen; Mack Barnes; Jeffrey Elder; Deanna Teoh; C Bethan Powell; Veena Choubey; Stephanie Blank; Heather R Macdonald; Mark F Brady; Diana L Urbauer; Diane Bodurka; David M Gershenson; Karen H Lu
Journal: Gynecol Oncol Date: 2011-01-28 Impact factor: 5.482

Review 4. Hysterectomy in the Urologist's Practice.

Authors: Steven J Weissbart; Ariana L Smith
Journal: Curr Urol Rep Date: 2017-01 Impact factor: 3.092

5. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

Authors: Panagiotis A Konstantinopoulos; Dimitrios Spentzos; Beth Y Karlan; Toshiyasu Taniguchi; Elena Fountzilas; Nancy Francoeur; Douglas A Levine; Stephen A Cannistra
Journal: J Clin Oncol Date: 2010-06-14 Impact factor: 44.544

6. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.

Authors: Shannon N Westin; Charlotte C Sun; Karen H Lu; Kathleen M Schmeler; Pamela T Soliman; Robin A Lacour; Kristin G Johnson; Molly S Daniels; Banu K Arun; Susan K Peterson; Diane C Bodurka
Journal: Cancer Date: 2010-12-29 Impact factor: 6.860

Specific keynote: hereditary ovarian cancer: what we know.

1. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.

2. Recent progress in the diagnosis and treatment of ovarian cancer.

3. Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

Review 4. Hysterectomy in the Urologist's Practice.

5. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

6. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.

7. Myriad Genetics: In the eye of the policy storm.

Review 8. Ovarian cancer biomarker discovery based on genomic approaches.

Review 9. Opportunistic salpingectomy for ovarian cancer prevention.

Review 10. Ovarian surface epithelium: family history and early events in ovarian cancer.